Blog

Nov 8, 2024, 18:44

Mamtha Balla: Tackling TIL therapy challenges in COVID-19

Mamtha Balla, Transplant Oncology-ID fellow at MD Anderson Cancer Center, shared a post on X:

”I am excited to present our Supriya Peshin poster on Tackling TIL therapy challenges in COVID-19 patients at the IOTOX symposium in Houston MD Anderson Cancer Center, Texas!

I’m thrilled to express my gratitude to IOTOX for allowing me to spotlight an incredibly significant topic—TIL, which has just received approval for solid cancers in February 2024!

It’s vital to grasp the distinctions between CART and TIL, and we must also navigate patient care for those with COVID-19 amidst these advancements. The possibilities in this field are fascinating!

Thanks to my mentors Pablo Okhuysen and Javier Adachi, Roy Chemaly for supporting me!”

cancer CART COVID-19 H.O.M.E Hem-Onc Fellows Network Houston IMG Oncologists IOTOX symposium IOTOX2024 Javier Adachi Mamtha Balla MD Anderson Cancer Center OncoDaily Oncology Pablo Okhuysen Roy Chemaly SITC 2024 Supriya Peshin Texas TIL TIL Therapy UTHealth Houston Infectious Diseases Women in Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success